Amedisys to Acquire AseraCare Hospice for $235 Million

Hospice and home health provider Amedisys, Inc. (NASDAQ:AMED) has entered into a definitive agreement to purchase Texas-based AseraCare Hospice for a cash purchase price of $235 million. Amedisys has had its eye on AseraCare for a number of years. “In 2016 we actually approached the AseraCare, and at that time they weren’t for sale. We’ve […]

Aseracare Settles False Claims Act Suit for $1 million

Hospice provider AseraCare has agreed to a $1 million settlement with the U.S. Department of Justice in a longstanding Qui Tam False Claims Act (FCA) case that began in 2008. The outcome of the case could set an important precedent as FCA suits continue to be the most prevalent enforcement actions that target hospices in […]

Hospice Legislation Comes Closer to House Vote

The number of cosponsors for the Palliative Care and Hospice Education and Training Act has reached the 290 the bill needs to come to a vote in the U.S. House of Representatives. A second bill, the Rural Access to Hospice Act, will likely be folded into a larger yet-to-be-determined piece of legislation. If enacted, PCHETA […]

Court: Difference of Opinion is Not Hospice Fraud

The Eleventh Circuit Court of Appeals partially affirmed a decision in favor of Arkansas-based hospice provider AseraCare in False Claims Act (FCA) case that has widespread implications for the hospice industry. The appellate court agreed with the Northern District of Alabama that a mere difference of physician’s opinions on a terminal patient’s prognosis does not […]

WSJ Editorial Debates Hospice Fraud Case

A major fraud case centered around live hospice discharges is being argued not only in 11th Circuit Court of Appeals, but in the editorial pages of the Wall Street Journal. Kyle Clark and Andrew George, trial lawyers for the Washington-based law firm of Baker Botts published a recent editorial, “Medicare’s Hospice Rules Could Make Your […]